13D/13G Filings - Sarepta Therapeutics Inc. (SRPT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
12:30 pm
Purchase
2021-02-10 13G Sarepta Therapeutics, Inc.
SRPT
Capital Research Global Investors 8,024,130
10.200%
287,382increase
(+3.71%)
Filing
History
2021-02-10
12:26 pm
Purchase
2021-02-10 13G Sarepta Therapeutics, Inc.
SRPT
Capital Research Global Investors 7,736,748
9.800%
7,736,748increase
(New Position)
Filing
History
2021-02-10
11:52 am
Purchase
2020-12-31 13G Sarepta Therapeutics, Inc.
SRPT
The Vanguard Group 7,217,259
9.150%
832,471increase
(+13.04%)
Filing
History
2021-02-08
10:31 am
Sale
2021-02-05 13G Sarepta Therapeutics, Inc.
SRPT
FMR CORP 6,115,228
7.741%
-2,232,756decrease
(-26.75%)
Filing
History
2021-02-01
08:23 am
Purchase
2020-12-31 13G Sarepta Therapeutics, Inc.
SRPT
BLACKROCK INC
BLK
5,379,215
6.800%
738,930increase
(+15.92%)
Filing
History
Goto Prev, 0, 1